Internal Medicine, Gastroenterology · Purchase, NY
NPI
1205279247
Since 2013
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
3
Medicare group memberships
Hospitals
2
Hospital affiliations
3030 Westchester Ave
Purchase, NY, 10577
Phone (914) 682-6466
Groups this clinician bills Medicare through
Medicare paid, 2024
$338K
14,526 services
Medicare patients, 2024
297
Average age 73
Drug cost, 2024
$677K
700 prescriptions
Company payments, 2025
$126
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jared Macklin was code 99214 (office e&m - established), 161 times for 109 patients. In total Jared Macklin billed 14,526 services in 58 codes, and Medicare paid $338K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 161 | 109 | $102.92 | $17K |
| 45385 Colonoscopy - Lesion Removal | Office | 86 | 86 | $378.36 | $33K |
| 99204 Office E&M - New | Office | 76 | 76 | $129.14 | $9,815 |
| 45380 Lower GI Endoscopy - Other | Office | 61 | 61 | $101.67 | $6,202 |
| 43239 Upper GI Endoscopy | Office | 38 | 37 | $195.93 | $7,445 |
| 36415 Venipuncture Blood Collection | Office | 32 | 29 | $8.65 | $277 |
| 43239 Upper GI Endoscopy | Facility | 25 | 25 | $79.77 | $1,994 |
| 99203 Office E&M - New | Office | 24 | 24 | $78.38 | $1,881 |
| 99213 Office E&M - Established | Office | 24 | 21 | $73.78 | $1,771 |
| 45380 Lower GI Endoscopy - Other | Facility | 22 | 22 | $69.01 | $1,518 |
| 45385 Colonoscopy - Lesion Removal | Facility | 19 | 19 | $235.89 | $4,482 |
| 85025 Blood Count | Office | 17 | 17 | $7.61 | $129 |
| 80053 Clinical Chemistry | Office | 16 | 16 | $10.35 | $166 |
| 45381 Lower GI Endoscopy - Other | Office | 13 | 13 | $84.57 | $1,099 |
| 82728 Clinical Chemistry | Office | 12 | 12 | $13.36 | $160 |
By year: 2022 $179K for 3,863 services; 2023 $326K for 13,669 services; 2024 $338K for 14,526 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 32 | 29 | $8.65 | $277 |
| 85025 Blood Count | 17 | 17 | $7.61 | $129 |
| 80053 Clinical Chemistry | 16 | 16 | $10.35 | $166 |
| 82728 Clinical Chemistry | 12 | 12 | $13.36 | $160 |
| 83540 Clinical Chemistry | 11 | 11 | $6.34 | $69.74 |
| 84466 Clinical Chemistry | 11 | 11 | $12.50 | $138 |
Medicare prescription drug claims, 2024
In 2024, the drug Jared Macklin prescribed most often to Medicare patients was Omeprazole, with 187 prescriptions and refills. In total Jared Macklin wrote 700 Medicare prescriptions that cost $677K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Omeprazole Generic | 187 | 408 | 63 | $1,839 |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 109 | 109 | 105 | $5,854 |
| Pantoprazole Sodium Generic | 57 | 122 | 19 | $1,205 |
| Gavilyte-G Peg3350/Sod Sulf,bicarb,cl/Kcl | 38 | 38 | 37 | $495 |
| Famotidine Generic | 27 | 53 | Under 11 | $199 |
| Mesalamine Er Mesalamine | 24 | 44 | Under 11 | $6,322 |
| Skyrizi On-Body Risankizumab-Rzaa | 23 | 43 | Under 11 | $473K |
| Budesonide Dr Budesonide | 21 | 31 | Under 11 | $1,277 |
| Budesonide Ec Budesonide | 18 | 40 | Under 11 | $18K |
| Lubiprostone Generic | 16 | 22 | Under 11 | $3,411 |
| Linzess Linaclotide | 14 | 22 | Under 11 | $13K |
| Lansoprazole Generic | 13 | 39 | Under 11 | $887 |
| Metronidazole Generic | 13 | 20 | 11 | $158 |
| Humira(Cf) Pen Adalimumab | 13 | 13 | Under 11 | $84K |
| Mesalamine Generic | 12 | 28 | Under 11 | $10K |
Brand drugs: - claims; generic drugs: 558 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jared Macklin $126 ($126 in general payments such as food, travel and fees) from 2 companies. The largest payer was Abbvie Inc. with $103.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 5 | $103 |
| Olympus America Inc. | 1 | $22.49 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.